跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,532 条关于
“Biliary Atresia”
全部
2,532
临床试验
2,095
药物
67
机构
21
资讯
349
上个月
Ipsen's Phase III BOLD Trial of Bylvay in Biliary Atresia Misses Primary Endpoint
10天前
ProQR Doses First Participant in Phase 1 Study of AX-0811
上个月
Ipsen Upgrades 2026 Guidance on 23.5% Sales Growth, Positive Phase III Readouts, and Pipeline-Building Acquisitions
去年
Ipsen's Kayfanda (Odevixibat) Receives EU Approval for Cholestatic Pruritus in Alagille Syndrome
11个月前
ProQR Receives EMA Authorization to Begin Phase 1 Trial of AX-0810 RNA Editing Therapy for Cholestatic Diseases
去年
Ipsen Secures Dual CHMP Approvals for Rare Liver Disease Treatments Following Regulatory Strategy Shift
8个月前
ProQR Reports Positive Phase 1 Safety Data for RNA Editing Therapy AX-0810, Advances Pipeline Programs
去年
Harvard Apparatus Regenerative Technology and Capital Institute of Pediatrics Collaborate on Esophageal Atresia Treatment
去年
Harvard Apparatus Regenerative Technology Partners with Capital Institute of Pediatrics for Esophageal Atresia Treatment
去年
FDA Approves Zanidatamab (Ziihera) for HER2-Positive Biliary Tract Cancer
第 1 页,共 35 页
上一页
下一页